 |
 |

Efficacy of Imipramine and Chlordiazepoxide in Depressive and Anxiety Disorders Questioned-Reply
Richard J. Kahn, MD
Boston University Clinical Psychopharmacology Laboratory 270 Babcock St Boston, MA 02215
Ronald Lipman, Phd
Friends Hospital Roosevelt Boulevard and Adams Avenue Philadelphia, PA 19124
Arch Gen Psychiatry. 1987;44(1):97-98.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
Reply.—
Concerning the depressed cases, it should be stressed that 75% of the depressed sample met DSM-III criteria for a major depressive disorder and that all patients were required to be moderately depressed, as indexed by a score of at least 8 on the Raskin Depression Scale. In their inpatient studies, Raskin et al1 employed a score of 9 on this screen, while outpatient studies by Klerman and his colleagues2 used a score of 7. Moreover, as we pointed out in the above-referenced article (page 71), two of the 21 items of the New Clinical Drug Evaluation Units version of the Hamilton Depression Scale were not scored. Further, all patients were judged by experienced psychiatrists to be in need of pharmacologic treatment. In short, this is a bona fide clinically depressed sample.
While we do not know why these patients did not show as much improvement in their clinical
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|